203 related articles for article (PubMed ID: 15219414)
1. Oxandrolone blocks glucocorticoid signaling in an androgen receptor-dependent manner.
Zhao J; Bauman WA; Huang R; Caplan AJ; Cardozo C
Steroids; 2004 May; 69(5):357-66. PubMed ID: 15219414
[TBL] [Abstract][Full Text] [Related]
2. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
[TBL] [Abstract][Full Text] [Related]
3. Studies on steroid receptors in human and rabbit skeletal muscle - clues to the understanding of the mechanism of action of anabolic steroids.
Gustafsson JA; Saartok T; Dahlberg E; Snochowski M; Häggmark T; Eriksson E
Prog Clin Biol Res; 1984; 142():261-90. PubMed ID: 6709658
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor activities of p,p'-DDE, fenvalerate and phoxim detected by androgen receptor reporter gene assay.
Xu LC; Sun H; Chen JF; Bian Q; Song L; Wang XR
Toxicol Lett; 2006 Jan; 160(2):151-7. PubMed ID: 16125883
[TBL] [Abstract][Full Text] [Related]
5. Transfection with steroid-responsive reporter constructs shows glucocorticoid rather than androgen responsiveness in cultured Sertoli cells.
Denolet E; Gendt KD; Swinnen JV; Verrijdt G; Deboel L; Roskams T; Verhoeven G
J Steroid Biochem Mol Biol; 2006 Feb; 98(2-3):164-73. PubMed ID: 16388947
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor silences thioredoxin-interacting protein and competitively inhibits glucocorticoid receptor-mediated apoptosis in pancreatic β-Cells.
Harada N; Katsuki T; Takahashi Y; Masuda T; Yoshinaga M; Adachi T; Izawa T; Kuwamura M; Nakano Y; Yamaji R; Inui H
J Cell Biochem; 2015 Jun; 116(6):998-1006. PubMed ID: 25639671
[TBL] [Abstract][Full Text] [Related]
8. Analysis of co-factor function in a glucocorticoid-resistant small cell carcinoma cell line.
Waters CE; Stevens A; White A; Ray DW
J Endocrinol; 2004 Nov; 183(2):375-83. PubMed ID: 15531725
[TBL] [Abstract][Full Text] [Related]
9. Tetrahydrogestrinone is a potent but unselective binding steroid and affects glucocorticoid signalling in the liver.
Friedel A; Geyer H; Kamber M; Laudenbach-Leschowsky U; Schänzer W; Thevis M; Vollmer G; Zierau O; Diel P
Toxicol Lett; 2006 Jun; 164(1):16-23. PubMed ID: 16356667
[TBL] [Abstract][Full Text] [Related]
10. Polychlorinated biphenyls interfere with androgen-induced transcriptional activation and hormone binding.
Portigal CL; Cowell SP; Fedoruk MN; Butler CM; Rennie PS; Nelson CC
Toxicol Appl Pharmacol; 2002 Mar; 179(3):185-94. PubMed ID: 11906248
[TBL] [Abstract][Full Text] [Related]
11. Transactivation of glucocorticoid-inducible rat aryl sulfotransferase (SULT1A1) gene transcription.
Fang HL; Shenoy S; Duanmu Z; Kocarek TA; Runge-Morris M
Drug Metab Dispos; 2003 Nov; 31(11):1378-81. PubMed ID: 14570770
[TBL] [Abstract][Full Text] [Related]
12. A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists.
Wilson VS; Bobseine K; Lambright CR; Gray LE
Toxicol Sci; 2002 Mar; 66(1):69-81. PubMed ID: 11861974
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
14. FMS-like tyrosine kinase 3 interacts with the glucocorticoid receptor complex and affects glucocorticoid dependent signaling.
Asadi A; Hedman E; Widén C; Zilliacus J; Gustafsson JA; Wikström AC
Biochem Biophys Res Commun; 2008 Apr; 368(3):569-74. PubMed ID: 18261979
[TBL] [Abstract][Full Text] [Related]
15. Antiandrogens prevent stable DNA-binding of the androgen receptor.
Farla P; Hersmus R; Trapman J; Houtsmuller AB
J Cell Sci; 2005 Sep; 118(Pt 18):4187-98. PubMed ID: 16141232
[TBL] [Abstract][Full Text] [Related]
16. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
18. Relationship between glucocorticoid receptor signal pathway and androgen-independent prostate cancer.
Yan TZ; Jin FS; Xie LP; Li LC
Urol Int; 2008; 81(2):228-33. PubMed ID: 18758226
[TBL] [Abstract][Full Text] [Related]
19. Identification of endogenous glucocorticoid repressed genes differentially regulated by a glucocorticoid receptor mutant able to separate between nuclear factor-kappaB and activator protein-1 repression.
Bladh LG; Lidén J; Dahlman-Wright K; Reimers M; Nilsson S; Okret S
Mol Pharmacol; 2005 Mar; 67(3):815-26. PubMed ID: 15550679
[TBL] [Abstract][Full Text] [Related]
20. Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line.
Paris F; Rabeolina F; Balaguer P; Bacquet A; Sultan C
Gynecol Endocrinol; 2007 Apr; 23(4):193-7. PubMed ID: 17505938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
